Danazol treatment and acute myocardial infarction

Journal of Obstetrics and Gynaecology

Volumn 23, Issue 3, 2003, Pages 327-328

  Boos, C J ^a,b   Dawes, M ^a   Jones, R ^a   Farrell, T ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

^b NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; DANAZOL; HOMOCYSTEINE; RETEPLASE;

ACUTE HEART INFARCTION; ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; BLOOD EXAMINATION; CASE REPORT; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; ELECTROCARDIOGRAM; ENDOMETRIOSIS; FAMILY HISTORY; FEMALE; HUMAN; LABORATORY TEST; LEFT ANTERIOR DESCENDING CORONARY ARTERY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RISK FACTOR; ST SEGMENT ELEVATION; UTERUS BLEEDING;

EID: 0038715908     PISSN: 01443615     EISSN: None     Source Type: Journal    
DOI: 10.1080/01443610310000106064     Document Type: Article

References (3)

1. Alvarado R.G., Liu J.Y. and Zwolak R.M. (2001) Danazol and limb threatening thrombosis: two case reports. Journal of Vascular Surgery, 34, 1123-1126.
2. Corno M., Vallar G., Scarlato G. and Meola G. (1989) Danazol and internal carotid artery thrombosis. European Neurology, 29, 235-237.
3. Crook D., Sidhu M., O'Donnell M. and Stevenson J.C. (1992) Lipoprotein Lp(a) levels are reduced by danazol, an anabolic steroid. Atheroselerosis, 92, 41-47.